Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone

Journal of Affective Disorders

Volumn 62, Issue 3, 2001, Pages 187-198

  Agelink, Marcus W ^a   Majewski, Thomas ^a   Wurthmann, Cornelius ^b   Postert, Thomas ^a   Linka, Thomas ^a   Rotterdam, Sebastian ^a   Klieser, Eckhard ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Antidepressants side effects; Autonomic nervous system; Cardiovascular; Heart rate variability; Major depression; Mortality; Nefazodone

Indexed keywords

ANTIDEPRESSANT AGENT; LORAZEPAM; NEFAZODONE;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BREATHING; CARDIOVASCULAR FUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BLOOD PRESSURE; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; SEROTONIN; SYMPATHETIC NERVOUS SYSTEM; TRIAZOLES;

EID: 0035112492     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(99)00202-5     Document Type: Article

References (52)

1. Improvement of neurocardial vagal dysfunction after successful antidepressive treatment with electroconvulsive therapy
2. Alcoholism, peripheral neuropathy and cardiovascular autonomic neuropathy (CAN)
3. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults
4. Mortality in depressed patients treated with electroconvulsive therapy and antidepressants
5. Increases in heart rate variability with successful treatment in patients with major depressive disorder
6. An analysis of the time relations of electrocardiograms
7. An efficient algorithm for spectral analysis of heart rate variability
8. Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder
9. Perspectives on the relationship between cardiovascular disease and affective disorder
10. An open trial of nefazodone in high comorbidity panic disorder
11. Parasympathetic cardiovascular control in human disease: A critical review of methods and results
12. Nefazodone: Preclinical pharmacology of a new antidepressant
13. Autonomic neuropathy: Its diagnosis and prognosis
14. Cardiovascular tests of autonomic function and sympathetic skin responses in patients with major depression
15. An open trial of nefazodone in adult patients with generalized anxiety disorder
16. Physiological, biochemical and subjective parameters in anxiety patients with panic disorder during stress exposure as compared with healthy controls
17. Heart rate variation in patients treated with antidepressants. An index of anticholinergic effects?
18. Mortality in alcoholics with autonomic neuropathy
19. Autonomic correlates of antidepressant treatment using heart rate variability analysis
20. Heart rate variability in patients with coronary artery disease: Differences in patients with higher and lower depression scores
21. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction
22. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction
23. Enhanced cardiovascular and catecholamine responses in women with depressive symptoms
24. Standardization of clinical tests for practice and clinical trials
25. Mortality among patients with in involution melancholia
26. Variability of the QT measurement in healthy men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmia
27. Increased heart rate in depressed subjects in spite of unchanged autonomic balance
28. The influence of autonomic neuropathy on mortality in insulin-dependent diabetes
29. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites
30. High fatality rates of late-life depression associated with cardiovascular disease
31. The effects of amitriptyline, doxepine, fluvoxamine, and paroxetine treatment on heart rate variability
32. Are affective disorders associated with alterations of heart rate variability?
33. The safety profile of nefazodone
34. Cardiovascular effects of fluoxetine in depressed patients with heart disease
35. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease
36. Cardiovascular effects of serotonin agonists and antagonists
37. Heart rate variability before and after treatment with electroconvulsive therapy
38. Autonomic function in panic disorder: Cardio-respiratory and plasma catecholamine responsivity to multiple challenges of the autonomic nervous system
39. Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy
40. Heart rate variability
41. Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug
42. Premature death in schizophrenia and affective disorders. An analysis of survival curves and variables affecting the shortened survival
43. Paroxetine increases heart rate variability in panic disorders
44. Cardiovascular variability in major depressive disorder and effects of imipramine and mirtazapine
45. Anxiety and autonomic regulation in major depressive disorder: An exploratory study
46. An improved method of measuring heart rate variability: Assessment of cardiac autonomic function
47. Heart rate variability in patients with major depression
48. Decreased heart rate variability in panic disorder patients: A study of power spectral analysis of heart rate
49. The effect of nefazodone on comorbid anxiety symptoms associated with depression: Experience in family practice and psychiatric outpatient settings
50. Assessment of cardiovascular autonomic function: Age-related normal ranges and reproducibility of spectral analysis, vector analysis and standard tests of heart rate variation and blood pressure response